FDA Strengthens Blood Clot Warnings On Testosterone Drugs
The U.S. Food and Drug Administration on Friday said it is requiring testosterone drug manufacturers to include a wider warning about the increased risk of blood clots in the veins....To view the full article, register now.
Already a subscriber? Click here to view full article